Repeat antivenom administration following crotalidae immune F(ab’)2 antivenom in Agkistrodon species: a case series
Open Access
- 2 December 2023
- journal article
- research article
- Published by Taylor & Francis in Toxicology Communications
- Vol. 7 (1)
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Predictors of FabAV use in copperhead envenomationClinical Toxicology, 2022
- Control of venom-induced tissue injury in copperhead snakebite patients: a post hoc sub-group analysis of a clinical trial comparing F(ab’)2 to Fab antivenomClinical Toxicology, 2021
- Use of Crotalidae equine immune F(ab’)2 antivenom for treatment of an Agkistrodon envenomationClinical Toxicology, 2021
- Review of North American pit viper antivenomsAmerican Journal of Health-System Pharmacy, 2020
- Prevalence of hematologic toxicity from copperhead envenomation: an observational studyClinical Toxicology, 2019
- The Epidemiology, Clinical Course, and Management of Snakebites in the North American Snakebite RegistryJournal of Medical Toxicology, 2017
- Lack of Coagulopathy After Copperhead SnakebitesAnnals of Emergency Medicine, 2015
- Comparison of F(ab’) 2 versus Fab antivenom for pit viper envenomation: A prospective, blinded, multicenter, randomized clinical trialClinical Toxicology, 2014